Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $109.14 | 6 | 52.5% |
| Education | $98.74 | 2 | 47.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $98.74 | 2 | $0 (2018) |
| JAZZ PHARMACEUTICALS INC. | $45.41 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $34.66 | 2 | $0 (2020) |
| Aurobindo Pharma USA, Inc. | $15.50 | 1 | $0 (2019) |
| Genentech USA, Inc. | $13.57 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $17.22 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($17.22) |
| 2019 | $78.35 | 4 | JAZZ PHARMACEUTICALS INC. ($45.41) |
| 2018 | $98.74 | 2 | Amgen Inc. ($98.74) |
| 2017 | $13.57 | 1 | Genentech USA, Inc. ($13.57) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2020 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Oncology | ||||||
| 07/16/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug), Aliqopa | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 05/09/2019 | Aurobindo Pharma USA, Inc. | Folotyn (Drug) | Food and Beverage | Cash or cash equivalent | $15.50 | General |
| Category: Oncology | ||||||
| 05/15/2018 | Amgen Inc. | — | Education | In-kind items and services | $16.24 | General |
| 04/10/2018 | Amgen Inc. | — | Education | In-kind items and services | $82.50 | General |
| 01/12/2017 | Genentech USA, Inc. | Avastin (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: BioOncology | ||||||
About Dr. Renu Pandit, M.D
Dr. Renu Pandit, M.D is a Hematology & Oncology healthcare provider based in Dearborn, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558324129.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Renu Pandit, M.D has received a total of $207.88 in payments from pharmaceutical and medical device companies, with $17.22 received in 2020. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($109.14).
Practice Information
- Specialty Hematology & Oncology
- Location Dearborn, MI
- Active Since 04/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1558324129
Products in Payments
- VYXEOS (Drug) $45.41
- Vitrakvi (Drug) $34.66
- Folotyn (Drug) $15.50
- Avastin (Biological) $13.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Dearborn
Faisal Musa, Md, MD
Hematology & Oncology — Payments: $922,775
Dr. Mirna Farhat, Md, MD
Hematology & Oncology — Payments: $4,876
Oscar Signori, Md, MD
Hematology & Oncology — Payments: $3,731
Dr. Feroze Momin, Md, MD
Hematology & Oncology — Payments: $276.49